These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6312217)

  • 1. Viral vaccines.
    Kit M; Kit S
    Med Clin North Am; 1983 Sep; 67(5):1129-45. PubMed ID: 6312217
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes simplex virus vaccines.
    Meignier B; Roizman B
    Antiviral Res; 1985; Suppl 1():259-65. PubMed ID: 3002260
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant vaccinia virus: immunization against multiple pathogens.
    Perkus ME; Piccini A; Lipinskas BR; Paoletti E
    Science; 1985 Sep; 229(4717):981-4. PubMed ID: 2992092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus vaccines--where are we?
    Kit S; Kit M
    Clin Obstet Gynecol; 1985 Mar; 28(1):164-77. PubMed ID: 2985314
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
    Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer directions in vaccine development and utilization.
    Hilleman MR
    J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 8. New concepts: vaccines.
    Rapp F
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S341-4. PubMed ID: 6273265
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant vaccinia viruses as new live vaccines.
    Smith GL; Mackett M; Moss B
    Biotechnol Genet Eng Rev; 1984; 2():383-407. PubMed ID: 6100668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiherpetic cultural inactivated divaccine (experience in its preparation and study of its therapeutic effectiveness)].
    Bikbulatov RM; Demidova SA; Alekseeva AA; Cheglakov IuA; Kozlova VI
    Sov Med; 1983; (3):50-4. PubMed ID: 6304919
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of the hepatitis B virus surface, core and E antigen genes by stable rat and mouse cell lines.
    Gough NM; Murray K
    J Mol Biol; 1982 Nov; 162(1):43-67. PubMed ID: 6296407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase].
    Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D
    Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of virus polypeptide structure with attenuation of poliovirus type 1.
    Milstien JB; Walker JR; Eron LJ
    J Virol; 1977 Sep; 23(3):811-5. PubMed ID: 197272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
    Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
    J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of hepatitis B vaccine by applying genetic engineering technology].
    Miyanohara A; Matsubara K
    Nihon Rinsho; 1983 May; 41(5):1120-34. PubMed ID: 6355559
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpes vaccine.
    Mindel A
    Br J Vener Dis; 1984 Jun; 60(3):204-5. PubMed ID: 6329408
    [No Abstract]   [Full Text] [Related]  

  • 17. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
    Smith GL; Mackett M; Moss B
    Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence.
    Oxford JS; McGeoch DJ; Schild GC; Beare AS
    Nature; 1978 Jun; 273(5665):778-9. PubMed ID: 661986
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.
    Da Costa XJ; Jones CA; Knipe DM
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6994-8. PubMed ID: 10359827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered poxviruses: a novel approach to the construction of live vaccines.
    Paoletti E; Weinberg RL; Davis SW; Davis M
    Vaccine; 1984 Sep; 2(3):204-8. PubMed ID: 6099648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.